Literature DB >> 19833804

Platelet aggregation in intracranial stents may mimic in-stent restenosis.

M Mazighi1, J P Saint Maurice, D Bresson, Z Szatmary, E Houdart.   

Abstract

We report the case of an early ISR that was due to platelet aggregation despite correct observance of a standard antiplatelet regimen. Biologic testing showed clopidogrel inefficiency, and ISR disappeared on angiography after a loading dose of clopidogrel. This result suggested that the arterial lumen reduction was due to platelet aggregation rather than in-stent myointimal hyperplasia. This observation emphasizes the importance of verifying the efficacy of clopidogrel before placing a stent.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19833804      PMCID： PMC7963984          DOI： 10.3174/ajnr.A1778

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


  9 in total

1.  Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events.

Authors:  Rossella Marcucci; Rita Paniccia; Emilia Antonucci; Anna Maria Gori; Sandra Fedi; Cristina Giglioli; Serafina Valente; Domenico Prisco; Rosanna Abbate; Gian Franco Gensini
Journal:  Am J Cardiol       Date:  2006-08-31       Impact factor: 2.778

2.  Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease.

Authors:  Andrew O Maree; Ronan J Curtin; Michelle Dooley; Ronan M Conroy; Peter Crean; Dermot Cox; Desmond J Fitzgerald
Journal:  J Am Coll Cardiol       Date:  2005-10-04       Impact factor: 24.094

3.  Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction.

Authors:  Kenneth A Schwartz; Dianne E Schwartz; Khalid Ghosheh; Mathew J Reeves; Kimberly Barber; Anthony DeFranco
Journal:  Am J Cardiol       Date:  2005-04-15       Impact factor: 2.778

4.  Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting.

Authors:  Dominick J Angiolillo; Antonio Fernandez-Ortiz; Esther Bernardo; Celia Ramírez; Carlos Barrera-Ramirez; Manel Sabaté; Rosana Hernández; Raul Moreno; Javier Escaned; Fernando Alfonso; Camino Bañuelos; Marco A Costa; Theodore A Bass; Carlos Macaya
Journal:  Thromb Res       Date:  2005       Impact factor: 3.944

5.  US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results.

Authors:  David Fiorella; Elad I Levy; Aquilla S Turk; Felipe C Albuquerque; David B Niemann; Beverly Aagaard-Kienitz; Ricardo A Hanel; Henry Woo; Peter A Rasmussen; L Nelson Hopkins; Thomas J Masaryk; Cameron G McDougall
Journal:  Stroke       Date:  2007-02-08       Impact factor: 7.914

6.  Prevalence and risk factors for aspirin and clopidogrel resistance in cerebrovascular stenting.

Authors:  S Prabhakaran; K R Wells; V H Lee; C A Flaherty; D K Lopes
Journal:  AJNR Am J Neuroradiol       Date:  2007-11-07       Impact factor: 3.825

7.  Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results.

Authors: 
Journal:  Stroke       Date:  2004-04-22       Impact factor: 7.914

8.  The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis.

Authors:  O O Zaidat; R Klucznik; M J Alexander; J Chaloupka; H Lutsep; S Barnwell; M Mawad; B Lane; M J Lynn; M Chimowitz
Journal:  Neurology       Date:  2008-01-30       Impact factor: 9.910

9.  Limited early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions.

Authors:  Aino Lepäntalo; Kari S Virtanen; Juhani Heikkilä; Ulla Wartiovaara; Riitta Lassila
Journal:  Eur Heart J       Date:  2004-03       Impact factor: 29.983
  9 in total
  3 in total

1.  Tandem Short-length Multi-stent Construct for Emergent Revascularization of Occlusive Long-segment Left Middle Cerebral Artery In-stent Stenosis.

Authors:  Torin W Karsonovich; Brittany R Bolt; Ajeet Gordhan
Journal:  Cureus       Date:  2020-04-15

2.  Incidence of microemboli and correlation with platelet inhibition in aneurysmal flow diversion.

Authors:  M R Levitt; B V Ghodke; D K Hallam; L N Sekhar; L J Kim
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-27       Impact factor: 3.825

3.  Impacts of CYP2C19 Polymorphism and Clopidogrel Dosing on in-Stent Restenosis: A Retrospective Cohort Study in Chinese Patients.

Authors:  Min Zhang; Jiangrong Wang; Yong Zhang; Pei Zhang; Zhisheng Jia; Manyi Ren; Xiaomeng Jia; Liping Ma; Mei Gao; Yinglong Hou
Journal:  Drug Des Devel Ther       Date:  2020-02-19       Impact factor: 4.162
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.